The gut–brain–circadian axis in anxiety and depression: a critical review
Frontiers in Psychiatry · 30.10.2025 · 16
DOI: 10.3389/fpsyt.2025.1697200 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 30.10.2025. Verfasst von Jhommara Bautista und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Anxiety and depressive disorders rank among the most prevalent psychiatric conditions worldwide, yet remission rates remain unsatisfactory despite advances in pharmacological and psychotherapeutic interventions. The gut–brain axis has emerged as a transformative framework for understanding these disorders, emphasizing bidirectional communication between the central nervous system, the enteric nervous system, the endocrine and immune systems, and the gut microbiota. Preclinical studies demonstrate that germ-free or dysbiotic states exaggerate hypothalamic–pituitary–adrenal (HPA) reactivity, remodel synaptic plasticity, and induce anxiety- and depression-like behaviors, while fecal microbiota transplantation confirms the causal influence of microbial communities. Mechanistically, neural (e.g., vagal), endocrine (e.g., cortisol), immune (e.g., cytokine), and metabolic (e.g., short-chain fatty acids, tryptophan metabolites, bile acids) pathways converge to regulate mood and stress resilience. An underappreciated yet critical dimension of this model is circadian rhythmicity. Both host endocrine cycles and microbial communities exhibit diurnal oscillations that synchronize metabolism, immune activity, and neural signaling. Disruption of these rhythms, through factors such as sleep disturbance, irregular feeding, or shift work, alters microbial diversity, dampens metabolite oscillations, destabilizes HPA regulation, and enhances neuroinflammation, thereby amplifying vulnerability to psychiatric disorders. Collectively, evidence supports a model in which anxiety and depression are systemic conditions arising from integrated neural, immune, endocrine, metabolic, and circadian dysregulation, rather than isolated brain-based pathologies. This reconceptualization positions microbial taxa and metabolites as candidate biomarkers and therapeutic targets. Precision interventions, ranging from diet and psychobiotics to fecal microbiota transplantation, chrononutrition, and immune-modulatory strategies, offer promising avenues for personalized psychiatry.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
Zitieren
APA
Bautista, J., Hidalgo-Tinoco, C., Di Capua Delgado, M., Viteri-Recalde, J., Guerra-Guerrero, A., & López-Cortés, A. (2025). The gut–brain–circadian axis in anxiety and depression: a critical review. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1697200
Vancouver
Bautista J, Hidalgo-Tinoco C, Di Capua Delgado M, Viteri-Recalde J, Guerra-Guerrero A, López-Cortés A. The gut–brain–circadian axis in anxiety and depression: a critical review. Frontiers in Psychiatry. 2025;16. doi:10.3389/fpsyt.2025.1697200
BibTeX
@article{Bautista2025,
author = {Bautista, Jhommara and Hidalgo-Tinoco, Camila and Di Capua Delgado, Miranda and Viteri-Recalde, Juliana and Guerra-Guerrero, Antonio and López-Cortés, Andrés},
title = {The gut–brain–circadian axis in anxiety and depression: a critical review},
journal = {Frontiers in Psychiatry},
year = {2025},
volume = {16},
doi = {10.3389/fpsyt.2025.1697200}
}
EUVIMED